CLINICAL Data has announced the completed sale of Cogenics to Beckman Coulter.
15/04/2009
CLINICAL Data has announced it will present at the 2009 Future Leaders in the Biotech Industry Conference held on 2 April 2009.
27/03/2009
THE CSIRO has developed software which will standardise the clinical descriptions of patients’ symptoms, treatments and outcomes used in electronic health records around the world.
06/02/2009
CLINICAL Data has announced a collaboration and licensing agreement with CombinatoRx to develop an adenosine A2A agonist compound in a combination therapy for the treatment of multiple myeloma, and other B-cell cancers.
18/08/2009
Australia is falling behind the rest of the world in the take-up of electronic solutions for clinical trials, says Jennie Anderson, CEO of Evado, a clinical software company.
07/12/2009
developments in laboratory medicine and attracted over 18,000 physicians, scientists and others involved in laboratory medicine in hospitals, universities, and private laboratories.
17/08/2009
CLINICAL Data have announced its Cogenics division has partnered with SinoGenoMax expanding its clinical genotyping service to the growing market in China.
21/01/2009
Lonza has entered into an agreement with Micromet for the process development and manufacture of Micromet’s blinatumomab (MT103).
25/11/2009
THE NATIONAL Health and Medical Research Council has awarded grants of up to $2.5 million each for six new Centres for Clinical Research Excellence (CCREs) to carry out high-quality clinical research.
02/07/2009
QUEENSLAND is breaking into one of the world's major markets for clinical trials of medical and pharmaceutical products and equipment.
18/09/2009
USCOM has announced the release of clinical guidelines for the management of septic shock in neonates, infants and children.
10/02/2009
THE NEW South Wales Governor, Professor Marie Bashir has opened the Department of Rural Health's extended clinical placement program.
30/06/2009
NOVARTIS has announced it has been awarded the worldwide rights to Elinogrel, a Phase II anti-clotting compound with potential to reduce risk of heart attack and stroke.
18/02/2009
Dr Neil Frazer, Prima BioMed's Chief Medical Officer will oversee clinical trials in the US for the company's CVac ovarian cancer vaccine treatment.
27/11/2009
INTERCELL has announced its Phase I clinical trail for bacterium Streptococcus pneumoniae vaccine candidate IC47 is underway.
08/04/2009
EMILY Walvoord, M.D., associate professor of clinical pediatrics at the Indiana University School of Medicine says that the trial she coordinated at Riley Hospital for Children has found that inhaled growth hormone (GH) is well tolerated by children with GH deficiency and that this easy-to-use method can, over a one-week period, safely deliver GH to the blood stream.
30/06/2009
THE COMMITTEE for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has adopted a negative opinion for the use of Erbitux (cetuximab) in combination with platinum-based chemotherapy for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing, advanced or metastatic nonsmall cell lung cancer (NSCLC).
28/07/2009
Bayer Schering Pharma will collaborate with Micromet on a novel approach to cancer therapy involving the use of a new antibody to treat solid tumours.
04/12/2009
NEWHAM University Hospital has placed a clinical chemistry analyser in its ‘hot lab’ increasing its point-of-care testing (POCT) facilities.
20/01/2009
EXPRESSION Pathology has received $6.5m ($A9.3m) additional financing from biotechnology company Abraxis BioScience.
21/04/2009